Rosevault

Rosevault
Your cycle data never leaves your device with zero-knowledge architecture on iOS.
About
Pricing
View pricing page ↗
What does Rosevault do?
RoseVault is a privacy-first period and cycle tracker for iOS that keeps all user data entirely on the device with zero cloud storage or tracking. It offers smart cycle tracking with on-device insights into mood, energy, sleep, and symptoms, all protected by AES-256 encryption and biometric locks. RoseVault serves individuals who prioritize the absolute privacy and security of their intimate health data.
Is Rosevault trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Rosevault is 52 out of 100, based on site security posture and privacy practices.
When was Rosevault founded?
Rosevault was founded in 2026.
What industry does Rosevault operate in?
Rosevault operates in HealthTech, FemTech, Privacy, Consumer App, Mobile App.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
